Sole Pharma – Launches in the Philippines to Meet Rising Demand for High-Quality Supplements
MANILA, Philippines, March 3, 2025 /PRNewswire/ -- In response to the growing demand for high-quality health supplements in the Philippines, Sole Pharma, as one of the leading European pharmaceutical manufacturer, announces its expansion into the Southeast Asian market. Products are available online through Mercury Drug, Watson's, Rose's Pharmacy and Allgreen RX, as well as on Sole Pharma's official Lazada and Shopee stores....
Sole Pharma – Launches in the Philippines to Meet Rising Demand for High-Quality Supplements
MANILA, Philippines, March 3, 2025 /PRNewswire/ -- In response to the growing demand for high-quality health supplements in the Philippines, Sole Pharma, as one of the leading European pharmaceutical manufacturer, announces its expansion into the Southeast Asian market. Products are available online through Mercury Drug, Watson's, Rose's Pharmacy and Allgreen RX, as well as on Sole Pharma's official Lazada and Shopee stores....
CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
SHANGHAI, March 3, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to...
Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that the first patient has been dosed in its registrational study evaluating IBI363, a first-in-class PD-1/IL-2α-bias bispecific antibody...
Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing
SHANGHAI, March 3, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has announced the closing of nearly $100 million Series C financing. This round was co-led by Qiming Venture Partners and existing shareholder Lilly Asia Ventures, with existing investors OrbiMed and Gaorong Capital participating on a super...
Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025
SAN DIEGO, March 3, 2025 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases, proudly announced the release of interim analysis of CSU (Chronic Spontaneous Urticaria) Phase II data for LP-003, the novel long-acting anti-IgE...
Hospital Kuala Lumpur & Rare Disease Patient Organizations Nationwide Celebrate Rare Disease Day 2025
KUALA LUMPUR, Malaysia, March 1, 2025 /PRNewswire/ -- For the first time, Hospital Kuala Lumpur (HKL) is proudly hosting the annual Rare Disease Day 2025 celebration to raise awareness and advocate for individuals affected by rare diseases in Malaysia. This milestone event is organized by the Department of Genetics, Hospital Kuala Lumpur, in collaboration with Pharm-D Health Science, the...
EMSRUN Medical Strengthens Middle East Footprint with Innovative Emergency Care Solutions at IDEX & NAVDEX 2025
ABU DHABI, UAE, March 1, 2025 /PRNewswire/ -- EMSRUN Medical, a leading supplier for tactical, pre-hospital, and civilian emergency medical solutions, proudly showcased its groundbreaking emergency care technologies and enhanced its brand presence in the Middle East at the International Defence Exhibition & Conference (IDEX) and the Naval Defence & Maritime Security Exhibition (NAVDEX) held in Abu Dhabi, UAE...
NUHS TRIBUTE AWARDS CEREMONY HONOURS EXEMPLARY HEALTHCARE PROFESSIONALS CHAMPIONING THE HEALTH SYSTEM OF THE FUTURE
The National University Health System (NUHS) honours 77 exceptional individuals and four teams driving transformative change in healthcare SINGAPORE, March 1, 2025 /PRNewswire/ -- The National University Health System (NUHS) is at the forefront of transforming healthcare, driving new models of care that extend beyond hospitals into the community. In recognition...
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory...
Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis Interim safety and pharmacokinetic data from healthy volunteers anticipated in 2H 2025 BOSTON, Feb. 28, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa), a clinical-stage biotechnology company developing novel biologics for inflammatory...
